LAURA DELEON: Open Payments
NPI 1265989800 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 12 payments from 8 companies in 2025. Trend: 2023 $822 · 2024 $459 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $65 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $44 |
| Sage Therapeutics, LLC | 2 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $28 |
| MILLICENT US INC | 1 | $28 |
| OptumHealth Care Solutions, LLC | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: Veozah, ZURZUVAE, Lynkuet, FEMLYV, VIVIFY HEALTH CARE TEAM PORTAL 001, MYFEMBREE, Qelbree.
Industry payments across NV — which companies pay providers there.
